Close
Show
Home Articles

Articles

The knowledge-based articles provided in this section are a collection of view points from research professionals and experts concerning various aspects of Pharmaceutical industry such as Drug Research, Pharmaceutical Production and Manufacturing, Strategies, Clinical Trails and Information technology.

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Modernas COVID-19 Vaccine

Optimizing cold chain and fill-finish capabilities for the coming wave of mRNA technologies

Samsung Biologics Online Topics
Reacting rapidly after the initial onset of the pandemic the biopharma industry accelerated its research into advanced anti-viral modalities including messenger RNA (mRNA) vaccines. As the pharma industry’s leaders responded to the crisis, the...

Transforming the clinical data management process with Agile

Tata Consultancy Services Limited Online Topics
Introduction The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis, and submission. Faster time to market puts pressure on every...

Biopharma 2022: 5 Trends Shaping the Industry

Vetter Online Topics
Just 10 months ago, pharma and biotech companies rode a wave of pandemic-driven innovation and historic funding levels into what many hoped would be another banner year. Now, after several quarters of shifting expectations,...
How to plan cGMP-compliant clinical batches

How to plan cGMP-compliant clinical batches

Vetter Online Topics
For companies developing new injectable medications, manufacturing issues have become one of the greatest and most consistent early stumbling blocks. In fact, the FDA has issued more than 600 manufacturing citations in just the...
The future of high-throughput screening

The future of high-throughput screening

Bruker Corporation Online Topics
High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific biological target. Mass spectrometry is particularly appealing for HTS as...
Converting Injectable Therapies to Combination Drug-Device Products

Converting Injectable Therapies to Combination Drug-Device Products

Vetter Online Topics
How to seize market opportunities while navigating the requirements of both drug therapies and delivery devices The global biopharma market has recently experienced a remarkable period of evolution and expansion. In that time, parenteral medications...
Soft mist nasal sprays ready to take the sting out of vaccine delivery

Soft mist nasal sprays ready to take the sting out of vaccine delivery

Recipharm Online Topics
The COVID-19 pandemic delivered many valuable lessons to the pharmaceutical industry, and emphasised the benefits of preparing for future pandemics. Wilbur de Kruijf at Recipharm argues how vaccines optimised for delivery by nasal administration...
Drug shortages and potential solutions to help mitigate them in the marketplace

Drug shortages and potential solutions to help mitigate them in the marketplace

AmerisourceBergen Corporation Online Topics
Collaborative Solutions to Address Supply Chain Vulnerabilities and Mitigate Drug Shortages The challenges of the last several years have shined a light on the pharmaceutical supply chain, revealing both its incredible strengths and opportunities for...
How to tackle top healthcare logistics challenges in 2022

How to tackle top healthcare logistics challenges in 2022

FedEx Express Online Topics
Combining the power of network with data paves the way for better logistical support for healthcare players.  The latest wave of COVID-19 infections has made its way across East Asia, with Hong Kong, Shanghai...

Selecting an optimized stability plan for your injectable drug product

Vetter Online Topics
No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: what’s the best approach to retaining the product’s stability? The answer is...